Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A ‘finger’ pointing the way to new hepatitis C medication

09.11.2012
Braunschweig scientists develop compounds with potential against Hepatitis C virus

Some 160 million men and women are infected with Hepatitis C virus (HCV), the most common cause of cirrhosis and cancer of the liver. The present standard therapy is thraught with serious side-effects leading to a cure in only half of the patients. New therapies utilise small molecules that inhibit specific steps in the viral reproduction. However, the pathogen rapidly develops resistance, becoming insensitive to these agents.


HCV-infected cells: green, fat-droplets, in which the virus is being assembled; red, parts of the virus; blue, the liver cell nucleus
TWINCORE / T. Pietschmann

Researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, in collaboration with colleagues from the TWINCORE in Hannover have discovered new drug leads that are also efficient against resistant virus. They present their work in the Journal of Biological Chemistry.

Interferons are used as classic medication against HCV as well as a few other viruses. Some interferons are produced naturally in the body in response to viral infection, others as immune modulators during inflammation. However, therapy with interferon is expensive, takes many months and has undesirable and unpleasant side effects. Hope was generated during the last few years through the development of a new generation of small drugs directed directly to the virus, in particular to those inhibiting the viral protease. These compounds inhibit viral replication by preventing the formation of the functional and structural components that must be cut out a precursor which the HCV virus instructs the host cell to produce in a single ‘block’. This cutting, or processing, is initiated by the viral protease which mutates rapidly, generating resistant variants for which the protease-inhibitors have lost their effectivity.

Scientists from the group of Prof. John Collins at the HZI have succeeded in identifying novel small molecules that are active against HCV. “Our molecules use several sites of action in inhibiting the viral protease. Amongst these one which had not previously been addressed by existing protease inhibitors,” explains Dr. Jonas Kügler, one of the participating scientists from the HZI. “Thus our molecules are effective against resistant virus with the expectation that the development of resistance will be more difficult,” adds his colleague Dr. Stefan Schmelz from the group of Prof. Dirk Heinz. Kügler and Schmelz are the first authors on the publication. This work is a colaboration between the groups of Collins and Heinz and scientists from the TWINCORE, Hannover, in the institute of Prof. Thomas Pietschmann.

The development of the novel inhibitors used an approach which combined two different tactics: In one special iterative enrichment process using ‘empirical selection’, the scientists searched for small proteins that bound specifically to the desired target: the HCV protease. During the second step, suitable candidates were then slightly modified on the basis of ‘rational design’ and thus further optimized for the desired property. This resulted in molecules that have a strong inhibitory effect on the protease when added at a very low concentration. All of the molecules share a novel structural feature which the researchers call a ‘tyrosine-finger’. This binds a region in the viral protease that was not bound by other inhibitors previously investigated.

“We do not expect that these molecules can be directly used for clinical antiviral therapy“ says John Collins. “Our results are, however, of great significance for the development of novel therapeutics effective even on virus resistant to other small inhibitors.” In the continuing race between the virus and the scientists, the researchers have achieved a new head-lead, or should one say a finger that points in the right direction.

Original publication:
Jonas Kügler, Stefan Schmelz, Juliane Gentzsch, Sibylle Haid, Erik Pollmann, Joop van den Heuvel, Raimo Franke, Thomas Pietschmann, Dirk W. Heinz and John Collins
High affinity peptide inhibitors of the hepatitis C virus NS3-4A protease refractory to common resistant mutants
Journal of Biological Chemistry, 2012
DOI: 10.1074/jbc.M112.393843

Dr. Jan Grabowski | Helmholtz Zentrum
Further information:
http://dx.doi.org/10.1074/jbc.M112.393843
http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/a_finger_pointing_the_way_to_new_hepatitis_c_medication/

More articles from Life Sciences:

nachricht World’s Largest Study on Allergic Rhinitis Reveals new Risk Genes
17.07.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Plant mothers talk to their embryos via the hormone auxin
17.07.2018 | Institute of Science and Technology Austria

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Microscopic trampoline may help create networks of quantum computers

17.07.2018 | Information Technology

In borophene, boundaries are no barrier

17.07.2018 | Materials Sciences

The role of Sodium for the Enhancement of Solar Cells

17.07.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>